Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

InflaRx (IFRX) EBT (2016 - 2026)

InflaRx's EBT history spans 9 years, with the latest figure at -$8.0 million for Q1 2026.

  • On a quarterly basis, EBT rose 38.97% to -$8.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $9.0 million, a 336.1% increase, with the full-year FY2025 number at -$53.1 million, down 7.9% from a year prior.
  • EBT hit -$8.0 million in Q1 2026 for InflaRx, down from $41.6 million in the prior quarter.
  • Over the last five years, EBT for IFRX hit a ceiling of $495.4 billion in Q1 2023 and a floor of -$16.6 million in Q1 2022.
  • Historically, EBT has averaged $41.4 billion across 5 years, with a median of -$10.6 million in 2025.
  • The widest YoY moves for EBT: up 2981462.85% in 2023, down 797.68% in 2023.
  • Tracing IFRX's EBT over 5 years: stood at -$7.5 million in 2022, then tumbled by 75.22% to -$13.2 million in 2023, then skyrocketed by 454.76% to $46.9 million in 2024, then fell by 11.31% to $41.6 million in 2025, then tumbled by 119.31% to -$8.0 million in 2026.
  • Business Quant data shows EBT for IFRX at -$8.0 million in Q1 2026, $41.6 million in Q4 2025, and -$10.6 million in Q3 2025.